• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
CRVS

CRVS

Corvus Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD11.60

-0.09 (-0.77%)

Rating:C

Company Profile

CEO

Richard A. Miller

IPO Date

2016-03-23

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$11.76

Prev. Close

$11.69

Day Low

$11.36

Day High

$11.80

52W Low

$3.55

52W High

$26.95

Market Cap

$0.98B

Volume

1.60M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

12

Hold

1

Sell

0

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
13 Mar 2026OppenheimerOutperformOutperformmaintain
22 Jan 2026JefferiesBuyBuymaintain
21 Jan 2026BarclaysOverweightOverweightmaintain
21 Jan 2026
Oppenheimer
Outperform
Outperform
maintain
20 Jan 2026HC Wainwright & Co.BuyBuymaintain
20 May 2025MizuhoOutperformOutperformmaintain
9 May 2025OppenheimerOutperformOutperformmaintain
26 Mar 2025HC Wainwright & Co.BuyBuymaintain
26 Mar 2025OppenheimerOutperformOutperformmaintain
14 Jan 2025HC Wainwright & Co.BuyBuymaintain